The Global Fund, Angola and Chevron: together against malaria

Posted on: 02 July 2012 | Updates

The Global Fund and Angola signed a US$56 million agreement in June which consolidated all current malaria grants in the country into a single grant. The goal of the program, which has been supported by Chevron, is to reduce malaria-related morbidity by 60% in Angola by 2016.

Some of the activities include distributing insecticide treated bed nets to vulnerable people like pregnant women and children under five to prevent them from contracting the disease. Resources are also used for the training of health workers and the expansion of access to anti-malaria treatment through nationwide health facilities.

Chevron, the Global Fund’s corporate champion, has supported the malaria program implemented by Angola’s Ministry of Health through a contribution to the Global Fund.

In addition to contributing US$ 5 million to this program, Chevron is partnering with the Ministry of Health in Angola to help educate its employees and the community about malaria. 

Minister of Health, José Dias Van-Dúnem and CCM Chair, Vice-Minister of Education, Ana Paula Ndala Fernando signed the agreement in Luanda.

Recent Blog Posts

  • 23 July 2014

    Candlelight Vigil in Melbourne

    A candlelight vigil was held in Melbourne’s Federation Square on the evening of 22 July, keeping up a tradition at each International AIDS Conference

  • 22 July 2014

    Better and Smarter Investments

    At the International AIDS Conference underway this week in Melbourne, Australia, Mark Dybul, Executive Director of the Global Fund, gave a presentation on how better and smarter investments can lead to a powerful shift in the HIV situation

  • 22 July 2014

    Global Fund News Flash: Issue 45

    AIDS Conference in Australia, New Drug in TB Response, Leading a New Regiment in Rwanda

  • 22 July 2014

    Defeating Discrimination and the HIV Epidemic

    This week, thousands of people from all over the world will convene in Melbourne to evaluate the global response to HIV/AIDS, and to focus on discrimination